BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 9990065)

  • 1. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
    Munroe DG; Gupta AK; Kooshesh F; Vyas TB; Rizkalla G; Wang H; Demchyshyn L; Yang ZJ; Kamboj RK; Chen H; McCallum K; Sumner-Smith M; Drucker DJ; Crivici A
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1569-73. PubMed ID: 9990065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.
    Yusta B; Somwar R; Wang F; Munroe D; Grinstein S; Klip A; Drucker DJ
    J Biol Chem; 1999 Oct; 274(43):30459-67. PubMed ID: 10521425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human glucagon-like peptide-1 (GLP-1) receptor. Cloning and functional expression.
    Dillon JS; Wheeler MB; Leng XH; Ligon BB; Boyd AE
    Adv Exp Med Biol; 1997; 426():113-9. PubMed ID: 9544263
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling.
    Lovshin J; Estall J; Yusta B; Brown TJ; Drucker DJ
    J Biol Chem; 2001 Jun; 276(24):21489-99. PubMed ID: 11262390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.
    Shin ED; Estall JL; Izzo A; Drucker DJ; Brubaker PL
    Gastroenterology; 2005 May; 128(5):1340-53. PubMed ID: 15887116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport.
    Lee J; Koehler J; Yusta B; Bahrami J; Matthews D; Rafii M; Pencharz PB; Drucker DJ
    Mol Metab; 2017 Mar; 6(3):245-255. PubMed ID: 28271031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway.
    Yusta B; Boushey RP; Drucker DJ
    J Biol Chem; 2000 Nov; 275(45):35345-52. PubMed ID: 10940305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide 2 function in domestic animals.
    Burrin DG; Stoll B; Guan X
    Domest Anim Endocrinol; 2003 Mar; 24(2):103-22. PubMed ID: 12586312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways.
    Koehler JA; Yusta B; Drucker DJ
    Mol Endocrinol; 2005 Feb; 19(2):459-73. PubMed ID: 15471943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.
    Heller RS; Kieffer TJ; Habener JF
    Biochem Biophys Res Commun; 1996 Jun; 223(3):624-32. PubMed ID: 8687446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2.
    Drucker DJ; Lovshin J; Baggio L; Nian M; Adatia F; Boushey RP; Liu Y; Saleh J; Yusta B; Scrocchi L
    Ann N Y Acad Sci; 2000; 921():226-32. PubMed ID: 11193827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa.
    Walsh NA; Yusta B; DaCambra MP; Anini Y; Drucker DJ; Brubaker PL
    Endocrinology; 2003 Oct; 144(10):4385-92. PubMed ID: 12960094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
    Drucker DJ
    Mol Endocrinol; 2003 Feb; 17(2):161-71. PubMed ID: 12554744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine.
    Lovshin J; Yusta B; Iliopoulos I; Migirdicyan A; Dableh L; Brubaker PL; Drucker DJ
    Endocrinology; 2000 Nov; 141(11):4194-201. PubMed ID: 11089553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator.
    Thulesen J
    Curr Protein Pept Sci; 2004 Feb; 5(1):51-65. PubMed ID: 14965320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
    Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
    Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transduction of the GLP-1-receptor cloned from a human insulinoma.
    van Eyll B; Lankat-Buttgereit B; Bode HP; Göke R; Göke B
    FEBS Lett; 1994 Jul; 348(1):7-13. PubMed ID: 7517895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide 2.
    Drucker DJ
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1759-64. PubMed ID: 11297614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.
    Liu X; Murali SG; Holst JJ; Ney DM
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1794-802. PubMed ID: 18832087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.